Stocks · News reference
Cellyan Biotechnology Granted 180‑Day Nasdaq Extension To Regain Compliance
Cellyan Biotechnology Co., Ltd (NASDAQ:HKPD) (the "Company"), a leading provider of over the counter ("OTC") pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 16, 2026, 8:32 PM
- Checked
- Jul 16, 2026, 8:32 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Why Callan JMB Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
Callan JMB Inc (CJMB) shares jumped 63.8% in pre-market trading after announcing a strategic partnership with Alabama State University.
Read original at benzingaCellyan Biotechnology Stock Sinks 21% After Hours: Here's What Happened
Cellyan Biotechnology shares fell in after-hours trading after the company announced a Nasdaq listing compliance update.
Read original at benzingaHKPD stock has given up its prior gain. Cellyan Biotechnology shares were trading higher after the company announced it was granted a 180-day Nasdaq extension to regain compliance.
Read original at benzinga